SITAGLIPTIN PHOSPHATE (SITAGLIPTIN PHOSPHATE) — FDA Approval ANDA202473 (MYLAN PHARMS INC)
SITAGLIPTIN PHOSPHATE (SITAGLIPTIN PHOSPHATE) — FDA Approval ANDA202473 (MYLAN PHARMS INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: SITAGLIPTIN PHOSPHATE; Active ingredients: SITAGLIPTIN PHOSPHATE; Application number: ANDA202473.
| Brand name | SITAGLIPTIN PHOSPHATE |
|---|---|
| Active ingredients | SITAGLIPTIN PHOSPHATE |
| Application number | ANDA202473 |
| Sponsor | MYLAN PHARMS INC |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | None (Tentative Approval) |
| Products in application | 3 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →